Guthrie Introduces Bipartisan Cancer Drug Parity Act

WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02), along with Representatives Brian Higgins (D -NY-26), Doris Matsui (D-CA-6) and Gus Bilirakis (R-FL-12) this week introduced the Cancer Drug Parity Act, a bipartisan bill that would require health insurance plans that cover intravenous cancer treatments to also equally cover orally administered cancer medications.

“Due to great innovation, many cancer treatments can now be taken orally by a patient themselves, and I believe we must ensure these patients have full access to these important drugs,” said Guthrie. “Americans suffering from cancer should not have to choose between one treatment option or another based on how their insurance classifies each treatment. The Cancer Drug Parity Act will fix the discrepancy between cancer treatment drugs that are orally administered and those that are intravenously or injected and will allow patients and doctors to choose the treatment that is right and most effective for them.”

Read press release here